by Sandeep Gupta | Jul 20, 2021 | Cancer (solid tumor), Publication
Abstract BACKGROUND: A key therapeutic goal of metastatic renal cell carcinoma (mRCC) treatment is delayed disease progression. The degree to which early therapeutic success affects downstream outcomes is not well established. OBJECTIVE: To assess the...
by Sandeep Gupta | Jul 20, 2021 | Cancer (solid tumor), Publication
Abstract Introduction: Substantial unmet needs exist among patients with metastatic renal cell carcinoma (mRCC). This retrospective study evaluated treatment patterns as well as clinical and economic outcomes associated with first-line monotherapy...
by Sandeep Gupta | Mar 18, 2020 | Cancer (solid tumor), Publication
Abstract Authors: Krishnan Ramaswamy, Stanislav Lechpammer, Jack Mardekian, Ahong Huang, Neil M Schultz, Rickard Sandin, Li Wang, Onur Baser, Daniel J George Introduction: Prostate cancer (PC) is the second leading cause of cancer death among US men and accounts for...
by Sandeep Gupta | May 20, 2019 | Cancer (solid tumor), Publication
Abstract Authors: Lim J, Samuelsen C, Golembesky A, Shrestha S, Wang L, Griebsch I Aim: Evaluate duration of therapy among patients treated with afatinib or erlotinib as first-line therapy for non-small-cell lung cancer (NSCLC). Materials & methods: NSCLC patients...
by Sandeep Gupta | May 19, 2019 | Cancer (solid tumor), Publication
Abstract Authors: Kariburyo F, Wang Y, Cheng IE, Wang L, Morgenstern D, Xie L, Meadows E, Danella J, Cher ML. Background: The objective of this study was to describe overall survival and the management of men with favorable risk prostate cancer (PCa) within a...
by Sandeep Gupta | May 16, 2019 | Cancer (solid tumor), Publication
Abstract Authors: Sonpavde G, Huang A, Wang L, Baser O, Miao R. Objectives: To assess treatment patterns and outcomes of patients with metastatic castration-resistant prostate cancer (mCRPC) receiving first-line chemotherapy or antiandrogen therapy. Patients and...
